Benefits of Bayesian Optimal Interval (BOIN) Design for Early-phase Oncology Trials

Early-phase oncology trials must find the maximum tolerated dose safely. This paper compares the traditional 3+3 with the Bayesian Optimal Interval (BOIN) design and its advantages in flexibility and efficiency.